c c cc
PRESCRIBERS 1ST EDITION BY LUO K
c c c c c
AYINGO TEST BANK | 2024 UPDATE
c c c c c
, Table of Contents
c c
Chapterc 1:cAncIntroductionctocEvidence-BasedcClinicalc PracticecGuidelines ................................................ 3
Chapterc2:cPharmacokineticsc /Chapter3:cPharmacodynamics...................................................................... 13
Chapter4:cPharmacogeneticsc andcPharmacogenomics ................................................................................. 25
Chapterc 5:cPharmacologycAcrosscthecLifecSpan .......................................................................................... 30
Chapterc 6:cDrug-TherapycPrescribingcincSpecialcPopulations...................................................................... 36
Chapterc 7:cDrugcDevelopmentc andcApproval .............................................................................................. 45
Chapterc8-Chapterc10:cFoundationscofcPrescriptioncWritingcChapterc9:cResponsibleControlled-
SubstancecPrescribingcChapterc10:cAntibioticcStewardship.......................................................................... 51
Chapterc 11:cAppliedcCalculationsc forc Prescribing ....................................................................................... 58
Chapterc12-:cPromotingcAdherencecWithcPharmacotherapycII:cSystem-SpecificcandcPatient-
FocusedcPrescribingcChapterc13:cPharmacotherapycforcEar,cNose,cMouth,candThroatcConditionsc/Chapterc1
4:cPharmacotherapycforcEyecConditions....................................................................................................... 67
Chapterc15:cPharmacotherapycforc SkincConditions ..................................................................................... 74
Chapterc 16:cPharmacotherapycforc Neurologicc Conditions ........................................................................... 81
Chapterc 17:cPharmacotherapycforc Cardiovascularc Conditions .................................................................... 94
Chapterc 18:cPharmacotherapycforc RespiratorycConditions ........................................................................ 106
Chapterc19:cPharmacotherapycforcGastrointestinalcConditionscandcConditionscRequiringNutritionalcSupport
................................................................................................................................................................... 117
Chapterc 20:cPharmacotherapycforc GenitourinarycConditions..................................................................... 128
Chapterc21:cPharmacotherapycforc Renal,cAcid–Base,c Fluid,candcElectrolytecDisorders ............................ 133
Chapterc 22:cPharmacotherapycforc MusculoskeletalcandcRheumatologiccConditions................................. 146
Chapterc23:cTherapeuticc Applicationsc ofcImmunologycandc Vaccines ....................................................... 158
Chapterc 24:cPharmacotherapycforc EndocrinecDisorders ............................................................................ 163
Chapterc25:cPharmacotherapycforcHematologiccDisorders ........................................................................ 174
Chapterc 26:cHematology/OncologycandcSupportivecCarecforcthecNononcologist ...................................... 190
Chapterc 27:cPharmacotherapyc RelatedctocWomen’scHealthcConditions .................................................... 196
Chapterc28:cPharmacotherapycRelatedctocMen’sc HealthcConditions.......................................................... 211
Chapterc 29:cPharmacotherapycRelatedctocTransgenderc Care ..................................................................... 217
Chapterc 30:cAntimicrobialcPharmacotherapy............................................................................................. 224
Chapterc 31:cAntiretroviralcPharmacotherapy ............................................................................................. 235
Chapterc32:cPsychopharmacologycandcIntegrativecHealth:cCombinedcTreatmentcofPsychiatriccandcNeuroco
gnitivec Conditions ...................................................................................................................................... 247
Chapterc 33:cPharmacotherapycforcPaincManagement ................................................................................ 257
Chapterc34:cSubstancecUsecDisorderc III:cHealthcPromotioncandcMaintenance .......................................... 267
Chapterc35:cOver-the-Counterc Medications............................................................................................... 283
Chapterc36:cPharmacotherapycforc Obesity ................................................................................................. 291
,Chapterc1:cAncIntroductionctocEvidence-BasedcClinicalcPracticecGuidelines
MULTIPLEcCHOICE
• Whatciscthecprimarycpurposec ofcthecnursingc assessment?
A. Identifyingc underlyingc pathologicc conditions
B. Assistingc thecphysiciancincidentifyingcmedicalc conditions
C. Determiningc thecpatientscmentalcstatus
D. Exploringc patientc responsesctoc healthc problems
ANS:cD
Acnursingcassessmentciscdonectocidentifycthecpatientscresponsectochealthcprob
lems.cDuringcthecnursingcassessmentcphase,caccomprehensivecinformationcba
seciscdevelopedcthroughcacphysicalcexamination,cnursingchistory,cmedicationc
history,candcprofessionalcobservation.cIdentifyingcunderlyingcpathologicccon
ditionscandcassistingcthecphysiciancincidentifyingcmedicalcconditionsciscnotcp
artcofcthecnursingcprocess.cDeterminingcthecpatientsc mentalcstatusc isconecpart
c ofcthec nursingc assessment,c butc itc isc notcthecprimarycpurpose.
DIF:cCognitivecLevel:cComprehensionc
REF:cdmc36cOBJ:c1c|c3cTOP:cNursingcPr
ocesscStep:cAssessment
MSC:cNCLEXc ClientcNeedsc Category:c HealthcPromotioncandc Maintenance
• WhatciscthecbasiscofcthecNANDAcIc taxonomy?
A. Functionalchealthcpatterns
B. Humancresponsecpatterns
C. Basicc humanc needs
D. Pathophysiologicc needs
ANS:cB
Thec NANDAc Ic taxonomyc identifiesc humanc responsec patterns.cFunctiona
lccomponentscofchealthcpatternscareclimitedctocactivity,cfluidcvolume,cnutriti
on,cselfccare,candcsensorycperception.cBasicchumancneedsccompriseclessctha
ncmerelychealthcpatterns.c Pathophysiologiccneedsc arecnotcpartcofcthecscopec
ofcNANDAcI.
, DIF:cCognitivecLevel:cKnowledgecREF
:cpp.c37-38cOBJ:c5cTOP:
NursingcProcesscStep:cDiagnosis
MSC:cNCLEXc Clientc Needsc Category:cPhysiologicalc Integrity
• Whichctaskciscincludedc incthecassessmentcstepc ofcthecnursingc process?
A. Establishingc patientc goals/outcomes
B. Implementingc thec nursingc carec planc (NCP)
C. Measuringc goal/outcomec achievement
D. Collectingcandc communicatingc data
ANS:cD
Datacareccollectedcandccommunicatedcincthecassessmentcphasecofcthecnursing
cprocess.cEstablishingcgoalsciscthecfunctioncofcplanning.
ImplementingcthecNCPciscthecfunctioncofcimplementation.cMeasuringcoutco
mecachievementciscthecfunctioncofcevaluation.
DIF:cCognitivecLevel:cComprehensionc
REF:cdmc36cOBJ:c2c|c3cTOP:cNursingcPr
ocesscStep:cAssessment
MSC:cNCLEXc ClientcNeedsc Category:c HealthcPromotioncandc Maintenance
• Whichcstatementcregardingc nursingcdiagnosesc isc accurate?
a. Nursingcdiagnosescremaincthecsamec forcasc longcascthecdiseasec isc present.
b. Nursingc diagnosesc arecwrittenctocidentifycdiseasecstates.
c. Nursingcdiagnosescdescribec patientcproblemscthatc nursesc treat.
d. Nursingcdiagnosesc identifyccausesc relatedctocillness.
ANS:cC
Diagnosticcstatementscidentifycproblemscacnurseciscindependentlycablectoctre
atcwithincthecscopecofcprofessionalcpractice.cNursingcdiagnosescvarycwithcth
ecchangingcconditioncofcthecpatient.cThecresponsecpatternscarecuniquectocthec
patientcandcarecnotcdiseasecspecific.cNursingcdiagnosescdescribecthecpatients
chumancresponsecpattern.
DIF:c Cognitivec Level:c Comprehension